Avyxa Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVYXA HOLDINGS, and when can generic versions of AVYXA HOLDINGS drugs launch?
AVYXA HOLDINGS has four approved drugs.
There are three US patents protecting AVYXA HOLDINGS drugs.
There are eight patent family members on AVYXA HOLDINGS drugs in five countries and twelve supplementary protection certificates in seven countries.
Summary for Avyxa Holdings
| International Patents: | 8 |
| US Patents: | 3 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Avyxa Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | POSFREA | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 203050-002 | Mar 1, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avyxa Holdings | POSFREA | palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 203050-001 | Mar 1, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avyxa Holdings | PEMETREXED | pemetrexed dipotassium | POWDER;INTRAVENOUS | 210661-001 | Jun 28, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-003 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Avyxa Holdings | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 210852-001 | Jun 7, 2023 | RX | Yes | Yes | 10,849,916 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avyxa Holdings Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016005962 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2016149162 | ⤷ Sign Up |
| China | 107427486 | ⤷ Sign Up |
| China | 111728941 | ⤷ Sign Up |
| Poland | 3270912 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Avyxa Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2785706 | C02785706/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
| 0430190 | SPC/GB05/032 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PALONOSETRON OR AN ISOMER, MIXTURE OF ISOMERS, N-OXIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/306/001 20050322 |
| 2785706 | 122020000046 | Germany | ⤷ Sign Up | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
| 0432677 | 7/2005 | Austria | ⤷ Sign Up | PRODUCT NAME: PEMETREXED UND DESSEN PHARMAZEUTISCH ANNAHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/04/290/001 20040920 |
| 1667986 | 28/2013 | Austria | ⤷ Sign Up | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
